| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 24 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 24 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 24 |
| 3 | FLUDARABINE PHOSPHATE | 14 |
| 4 | ERGOCALCIFEROL | 10 |
| 5 | ALBUTEROL SULFATE | 9 |
| 6 | BOSENTAN | 9 |
| 7 | FUROSEMIDE | 9 |
| 8 | METHOTREXATE SODIUM | 9 |
| 9 | ACETAMINOPHEN | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLOROTHIAZIDE | 2 | 0.0016 |
| 1 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| 2 | EDARAVONE | 1 | 0.0006 |
| 3 | TOPOTECAN | 3 | 0.0005 |
| 4 | PEGASPARGASE | 6 | 0.0005 |
| 5 | AMPHOTERICIN B LIPOSOME | 1 | 0.0004 |
| 6 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 1 | 0.0004 |
| 7 | ALGLUCOSIDASE ALFA | 1 | 0.0004 |
| 8 | MERCAPTOPURINE | 7 | 0.0004 |
| 9 | FLUDARABINE PHOSPHATE | 14 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 25 |
| 1 | Corticosteroid [EPC] | 21 |
| 2 | Loop Diuretic [EPC] | 10 |
| 3 | Provitamin D2 Compound [EPC] | 10 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 9 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 9 |
| 6 | Proteasome Inhibitor [EPC] | 8 |
| 7 | Thalidomide Analog [EPC] | 8 |
| 8 | Aldosterone Antagonist [EPC] | 7 |
| 9 | Benzodiazepine [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 6 | 0.0004 |
| 1 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 3 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 4 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 5 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 6 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 7 | Complement 5a Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 9 | Prostacyclin Receptor Agonist [EPC] | 3 | 0.0001 |